Sign In
Buy NVS
$153.38
+4.45 (+2.99%)
At Close: Jun 23, 2026
Novartis to cut 680 jobs in product development
10:16am, Tuesday, 09'th Apr 2024
Novartis is to cut up to 680 jobs in its development organisation, which helps bring its drugs to market, the Swiss pharmaceuticals company said on Tuesday.
Novartis (NVS) Stock Sinks As Market Gains: Here's Why
07:06pm, Friday, 05'th Apr 2024
In the latest trading session, Novartis (NVS) closed at $95.79, marking a -1.14% move from the previous day.
Novartis To Seek Label Expansion of Prostate Cancer Treatment After Successful Study
04:15pm, Thursday, 04'th Apr 2024
Shares of Novartis (NVS) climbed Thursday as the pharmaceutical firm announced it would seek approval for expanded use of its cancer treatment, Pluvicto.
Novartis: Higher Guidance, Now A Buy
12:56am, Thursday, 04'th Apr 2024
Novartis is now a pure player in innovative medicines. Despite a negative FX, the company reported solid 2023 financial results and increased its dividend per share. There is a strategic rationale for
Novartis (NVS) Declines More Than Market: Some Information for Investors
07:21pm, Tuesday, 02'nd Apr 2024
In the most recent trading session, Novartis (NVS) closed at $94.41, indicating a -1.52% shift from the previous trading day.
The Magnificent 7 Of Dividend Aristocrats Yield As Much As 6%
07:00am, Saturday, 30'th Mar 2024
The market caps of the Magnificent Seven (Microsoft, Nvidia, Apple, Alphabet, Amazon, Tesla, Meta) have surpassed the stock market of some of the world's largest countries. The Mag 7 are great compani
Investors Heavily Search Novartis AG (NVS): Here is What You Need to Know
10:01am, Thursday, 28'th Mar 2024
Zacks.com users have recently been watching Novartis (NVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Novartis (NVS) Increases Yet Falls Behind Market: What Investors Need to Know
07:05pm, Wednesday, 27'th Mar 2024
Novartis (NVS) closed at $95.88 in the latest trading session, marking a +0.64% move from the prior day.
Harnessing AI for Drug Discovery: Top 3 Stocks to Watch
01:06pm, Tuesday, 26'th Mar 2024
Artificial intelligence (AI) spans above and beyond today's popular large language models (LLMs). OpenAI's ChatGPT-4 Turbo or even Anthropic's Claude 3 make for an impressive assistant for everyday ta
Novartis (NVS) Declines More Than Market: Some Information for Investors
07:16pm, Monday, 25'th Mar 2024
In the most recent trading session, Novartis (NVS) closed at $95.73, indicating a -0.52% shift from the previous trading day.
2 More Potential Biotech Buyout Targets
01:07pm, Monday, 25'th Mar 2024
M&A activity in the biotech/biopharma sector is expected to remain active due to significant cash on Big Pharma's balance sheets, key patent expirations, and declining revenue from Covid related produ
1 Magnificent Dividend Stock to Buy and Hold
08:15am, Sunday, 24'th Mar 2024
Novartis is an innovative drugmaker that delivers strong financial results. The Swiss pharmaceutical giant's dividend history is also impressive.
Novartis (NVS) Increases Yet Falls Behind Market: What Investors Need to Know
07:05pm, Tuesday, 19'th Mar 2024
In the most recent trading session, Novartis (NVS) closed at $96.32, indicating a +0.42% shift from the previous trading day.
3 Top Stocks to Watch From the Best International Money Managers
11:00am, Tuesday, 19'th Mar 2024
#Morningstar #NovoNordisk #StockInvesting Managers of highly rated funds own these foreign stocks. Should you?
Novartis (NVS) Stock Dips While Market Gains: Key Facts
07:20pm, Monday, 18'th Mar 2024
In the latest trading session, Novartis (NVS) closed at $95.92, marking a -1.39% move from the previous day.
